Pharmako Biotechnologies, Gencor’s partner company, developed PlexoZome®, a genuine liposomal delivery technology that increases bioavailability and format versatility. With various ready-to-go formulations, PlexoZome® technology is a cutting-edge innovation that improves the efficacy and capability of hydrophilic ingredients in the core and lipophilic in the bilayer, or both.

This Technical Paper is from Gencor.